Consensus Takeda Pharmaceutical Company Limited

Stocks

4502

JP3463000004

Pharmaceuticals

Market Closed - Japan Exchange 01:30:00 2026-11-06 EST			5-day change	1st Jan Change
6,560.00 ^JPY	-4.76%		-1.37%	+35.68%

11-05	Takeda Pharmaceutical Insider Sold Shares Worth $1,162,395, According to a Recent SEC Filing	MT
11-05	Asian Equities Traded in the US as American Depositary Receipts Drop Sharply in Thursday Trading	MT

Evolution of the Average Target: Takeda Pharmaceutical Company Limited

Evolution of the Target Price: Takeda Pharmaceutical Company Limited

Changes in Analyst Recommendations: Takeda Pharmaceutical Company Limited

d92aee82a15230f4f28d51ddb.mPh4KhLTvCKevemQnNcyx4s0BVLLDLMJ-WO5j341Nu4.0YgRQSu__VDa1aHH1edgheBabCWZTeJxiSCB3T9dXbnAgUh6W7_VTfzejg~39a2e7d503aec7ab94f0ec64ac16a8cf

Analysts' recommendations: Takeda Pharmaceutical Company Limited

10-29	Macquarie Adjusts Takeda Pharmaceutical's Price Target to 7,600 Yen	MT
08-31	Protagonist Therapeutics' Own Pipeline Seen as Main Long-Term Growth Driver, Wedbush Says	MT
07-28	SBI Securities Starts Takeda Pharmaceutical at Neutral with 5,400 Yen Price Target	MT
07-24	China Merchants Starts Takeda Pharmaceutical at Buy with 6,600 Yen Price Target	MT
03-30	Alumis' Drug 'Very Positive' for Treatment of Psoriasis, Systemic Lupus Erythematosus, Oppenheimer Says	MT
01-30	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,700 Yen From 5,100 Yen, Keeps at Buy	MT
11-11	Neurocrine Biosciences' Depressive Disorder Drug Fails to Meet Primary Goal in Phase 2 Study	MT
25-09-26	Alkermes' Stock Dip on Narcolepsy Data Seen as Buying Opportunity, RBC Says	MT
25-08-20	Veeva Systems Q2 Results Likely In-Line to Better, Maintain H2 Outlook, Truist Says	MT
25-05-09	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,100 Yen From 5,500 Yen, Keeps at Buy	MT
25-05-06	Jefferies Adjusts Takeda Pharmaceutical Company's Price Target to 5,500 Yen From 5,000 Yen, Keeps at Buy	MT
24-08-12	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,000 Yen From 4,800 Yen, Keeps at Buy	MT
24-07-31	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 4,800 Yen From 5,600 Yen, Keeps at Buy	MT
24-02-13	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,600 Yen From 5,200 Yen, Keeps at Buy	MT
23-10-03	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,200 Yen From 5,300 Yen, Keeps at Buy	MT
23-09-22	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,300 Yen From 5,100 Yen, Keeps at Buy	MT
23-05-31	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,100 Yen From 5,000 Yen, Keeps at Buy	MT
23-05-16	TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $20 From $30, Maintains Outperform Rating	MT
23-04-04	TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $30 From $24, Keeps Outperform Rating	MT
23-03-16	BofA Securities Upgrades Takeda Pharmaceutical to Buy From Neutral, Price Target $20	MT
23-03-06	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,000 Yen From 4,600 Yen, Keeps at Buy	MT
22-08-01	Jefferies Downgrades Takeda Pharmaceutical to Hold From Buy	MT
22-07-19	Cowen Upgrades Takeda Pharmaceutical to Outperform From Market Perform	MT
21-10-07	Takeda Pharmaceutical : Morgan Stanley Downgrades Takeda Pharmaceutical to Equal-weight From Overweight	MT
17-09-08	Bayer : Germany's Merck hires JP Morgan to sell consumer health	RE

More recommendations

Other Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	TAKEDA PHARMACEUTICAL COMPANY LIMITED					+3.9%
	ELI LILLY AND COMPANY					+7.34%
	JOHNSON & JOHNSON					+1.15%
	ABBVIE INC.					+6.64%
	ROCHE HOLDING AG					+1.08%
	MERCK & CO., INC.					+10.08%
	NOVARTIS AG					-6.85%
	ASTRAZENECA PLC					+15.51%
	AMGEN INC.					-6.66%
	GILEAD SCIENCES, INC.					+4.72%
	Average					+3.69%
	Weighted average by Cap.					+4.49%